BD to acquire Bard in $24 bln medical tech deal
23/04/2017 22:50
NEW YORK, April 23 (Reuters) - Becton Dickinson and Co
BDX.N will acquire C R Bard Inc BCR.N in a $24 billion deal
that will give shareholders of the target about 15 percent of
the combined entity, the two medical technology companies said
on Sunday.
The "definitive" cash and stock agreement, which has been
approved by directors of both companies, values Bard shares at
$317.00 each.
(Reporting by Jonathan Spicer and Ramavenkat Raman; Editing by
Mary Milliken)
((jonathan.spicer@thomsonreuters.com; +1 646 223 6253; Reuters
Messaging: jonathan.spicer.thomsonreuters.com@reuters.net
www.twitter.com/jonathanspicer))
Keywords: CR BARD M&A/BD